“We need automated solutions for taking the entire pipeline from start to finish. This end-to-end solution does not currently exist.”
On August 31, 2023 David McCall, Senior Editor, Cell & Gene Therapy Insights, spoke to Dhruv Sareen, Jonathan Rodriguez, and Hojae Lee from the Cedars-Sinai Biomanufacturing Center about challenges and progress in iPSC-derived cell therapy manufacturing. This article is based on that interview.
